Physician profile
John Zimmerman
NPI 1528036217
$11,644.51
in general payments reported to CMS, 2019-2025
30 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,368 · 2020: $1,407 · 2021: $1,856 · 2022: $835 · 2023: $3,252 · 2024: $447 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,015 · Travel and Lodging: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,015.39 |
| Travel and Lodging | $1,162.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,360.85 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Farapulse |
| Medtronic, INC. | $2,474.00 | 2021-2024 | Diamondtemp Bidirectional Ablation Catheter, Micra, Cobalt Dr Mri Surescan |
| Topera, INC. | $2,226.07 | 2019-2021 | |
| Medical Device Business Services, INC. | $980.77 | 2019 | |
| Medtronic Vascular, INC. | $379.56 | 2019-2020 | |
| Biosense Webster, INC. | $372.13 | 2019-2025 | Carto 3 |
| Biotronik INC. | $242.35 | 2019-2025 | Acticor 7 Vr-T Dx |
| Pfizer INC. | $170.86 | 2020-2024 | |
| Cvrx, INC. | $162.94 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.17 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $151.73 | 2019-2023 | Xarelto |
| Abbott Laboratories | $151.45 | 2019-2024 | Perclose Prostyle, Aveir |
| Sanofi-Aventis U.S. LLC | $135.25 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $101.60 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.55 | 2019-2024 | Jardiance |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $59.14 | 2022-2024 | Optimizer |
| Atricure, INC. | $55.41 | 2020-2022 | |
| Irhythm Technologies, INC. | $52.12 | 2020-2023 | Zio Xt Patch |
| Philips North America LLC | $50.58 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Baxter Healthcare | $50.22 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $40.05 | 2024 | Opsumit |
| G Medical Diagnostic Services, INC. | $31.43 | 2019-2022 | |
| Lundbeck LLC | $28.94 | 2019 | |
| Edwards Lifesciences Corporation | $28.28 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $25.60 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $24.12 | 2024 | Wainua |
| Cardiva Medical, INC. | $23.19 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ethicon US, LLC | $23.01 | 2025 | Ethicon |
| Novartis Pharmaceuticals Corporation | $14.95 | 2019 | |
| Bardy Diagnostics, INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Zimmerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.